Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2018

01-08-2018 | Original Paper

Reaching the First 90 in Uganda: Predictors of Success in Contacting and Testing the Named Sexual Partners of HIV+ Index Clients in Kiboga District

Authors: Katherine Buhikire, Joachim Voss, Joanita Kigozi, Patience Nyakato, Nickson Ankunda, Brenda Kalebbo, Michael Musiitwa, Alex Muganzi, Nelson K. Sewankambo, Damalie Nakanjako

Published in: AIDS and Behavior | Issue 8/2018

Login to get access

Abstract

Assisted partner notification programs represent one strategy for targeted HIV testing and treatment of exposed individuals in high-risk populations. This study of a pilot Partner Services program in rural Uganda describes predictors of successful contact tracings and testing of partners of HIV+ individuals and possible barriers to contact. Partner contact tracing data was extracted from registers at seven Ministry of Health facilities between May and October 2016, to inform program implementation and scale up. A total of 464 HIV+ index clients named 660 sexual partners; 334/660 (51%) were contacted, 193/334 (58%) tested for HIV, and 61/193 (32%) tested HIV+. Current relationship status predicted contact [AOR = 0.23; (95% CI 0.15, 0.37), p < 0.0001] and testing [AOR = 0.19; (95% CI 0.09, 0.36), p < 0.0001]. Partner contact information type was associated with contact (p < 0.0001), and assisted disclosure with testing (p < 0.0001). Partner contact tracing is an effective means of identifying undiagnosed HIV infections.
Appendix
Available only for authorised users
Literature
1.
European Partner Notification Study Group. Recently diagnosed sexually HIV-infected patients seroconversion interval, partner notification period and a high yield of HIV diagnoses among partners. QJM. 2001;94(7):379–90.CrossRef
2.
Kissinger P, Malebranche D. Partner notification: a promising approach to addressing the HIV/AIDS racial disparity in the United States. Am J Prev Med. 2007;33(2 Suppl):S86–7.CrossRefPubMed
3.
Brown LB, Miller WC, Kamanga G, et al. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr. 2011;56(5):437–42.CrossRefPubMedPubMedCentral
4.
Henley C, Forgwei G, Welty T, et al. Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries. Sex Transm Dis. 2013;40(12):909–14.CrossRefPubMedPubMedCentral
5.
6.
7.
8.
9.
10.
Cherutich P, Golden MR, Wamuti B, et al. Assisted partner services for HIV in Kenya: a cluster randomised controlled trial. Lancet HIV. 2017;4(2):e74–82.CrossRefPubMed
11.
Kamanga G, Brown L, Jawati P, Chiwanda D, Nyirenda N. Maximizing HIV partner notification opportunities for index patients and their sexual partners in Malawi. Malawi Med J. 2015;27(4):140–4.PubMedPubMedCentral
12.
Rosenberg NE, Mtande TK, Saidi F, et al. Recruiting male partners for couple HIV testing and counselling in Malawi’s option B+ programme: an unblinded randomised controlled trial. Lancet HIV. 2015;2(11):e483–91.CrossRefPubMedPubMedCentral
13.
Rutstein SE, Brown LB, Biddle AK, et al. Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan. 2014;29(1):115–26.CrossRefPubMed
14.
Kahabuka C, Plotkin M, Christensen A, et al. Addressing the first 90: a highly effective partner notification approach reaches previously undiagnosed sexual partners in Tanzania. AIDS Behav. 2017;21(8):2551–60.CrossRefPubMedPubMedCentral
15.
Tafuma TA, Ntwayagae BC, Moalafhi CK, Bolebantswe JM. Patient initiated sexual partner notification in Botswana and time taken for sexual contacts to report for treatment. S Afr Med J. 2014;104(1):42–4.CrossRef
16.
Kyabayinze DJ, Achan J, Nakanjako D, et al. Parasite-based malaria diagnosis: are health systems in Uganda equipped enough to implement the policy? BMC Public Health. 2012;12:695.CrossRefPubMedPubMedCentral
17.
Uganda Ministry of Health. Uganda partner services implementation guide. 2017. (Unpublished).
18.
Simbayi LC, Kalichman SC, Strebel A, Cloete A, Henda N, Mqeketo A. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007;83(1):29–34.CrossRefPubMed
19.
Winchester MS, McGrath JW, Kaawa-Mafigiri D, et al. Early HIV disclosure and nondisclosure among men and women on antiretroviral treatment in Uganda. AIDS Care. 2013;25(10):1253–8.CrossRefPubMedPubMedCentral
20.
Maman S, van Rooyen H, Groves AK. HIV status disclosure to families for social support in South Africa (NIMH Project Accept/HPTN 043). AIDS Care. 2014;26(2):226–32.CrossRefPubMed
21.
Mugasha C, Kigozi J, Kiragga A, et al. Intra-facility linkage of HIV-positive mothers and HIV-exposed babies into HIV chronic care: rural and urban experience in a resource limited setting. PLoS ONE. 2014;9(12):e115171.CrossRefPubMedPubMedCentral
22.
23.
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral
24.
Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, Sweat MD. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003;7(4):373–82.CrossRefPubMed
Metadata
Title
Reaching the First 90 in Uganda: Predictors of Success in Contacting and Testing the Named Sexual Partners of HIV+ Index Clients in Kiboga District
Authors
Katherine Buhikire
Joachim Voss
Joanita Kigozi
Patience Nyakato
Nickson Ankunda
Brenda Kalebbo
Michael Musiitwa
Alex Muganzi
Nelson K. Sewankambo
Damalie Nakanjako
Publication date
01-08-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2137-y

Other articles of this Issue 8/2018

AIDS and Behavior 8/2018 Go to the issue

Substantive Review

Strategies to Increase HIV Testing Among MSM: A Synthesis of the Literature

Original Paper

Mechanism of Change in Cognitive Behavioral Therapy for Body Image and Self-Care on ART Adherence Among Sexual Minority Men Living with HIV

Original Paper

Young Women’s Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa

Original Paper

Past Care Predicts Future Care in Out-of-Care People Living with HIV: Results of a Clinic-Based Retention-in-Care Intervention in North Carolina

Substantive Review

A Critical Review and Commentary on the Challenges in Engaging HIV-Infected Latinos in the Continuum of HIV Care

Original Paper

Exploring the Correlates of Linkage to HIV Medical Care Among Persons Living with HIV Infection (PLWH) in the Deep South: Results and Lessons Learned from the Louisiana Positive Charge Initiative
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits